State Street Corp Seres Therapeutics, Inc. Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 500,748 shares of MCRB stock, worth $7.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

500,748

Previous 500,748 -0.0%

Holding current value

$7.05 Million

Previous $415,000 15.66%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.55 - $0.98 $64,625 - $115,150	117,500 Added 30.66%	500,748 $415,000
Q3 2024 Nov 14, 2024	BUY	$0.7 - $1.48 $30,589 - $64,676	43,700 Added 12.87%	383,248 $364,000
Q2 2024 Aug 14, 2024	SELL	$0.56 - $1.19 $899,816 - $1.91 Million	-1,606,815 Reduced 82.55%	339,548 $244,000
Q1 2024 May 15, 2024	BUY	$0.75 - $1.56 $27,629 - $57,468	36,839 Added 1.93%	1,946,363 $1.5 Million
Q4 2023 Feb 14, 2024	SELL	$0.93 - $2.15 $7.09 Million - $16.4 Million	-7,626,366 Reduced 79.98%	1,909,524 $2.67 Million
Q3 2023 Nov 14, 2023	BUY	$2.33 - $5.07 $2.26 Million - $4.92 Million	970,955 Added 11.34%	9,535,890 $22.7 Million
Q2 2023 Aug 14, 2023	BUY	$4.67 - $6.55 $22.4 Million - $31.4 Million	4,796,626 Added 127.29%	8,564,935 $41 Million
Q1 2023 May 15, 2023	SELL	$4.95 - $6.09 $3.94 Million - $4.85 Million	-795,830 Reduced 17.44%	3,768,309 $21.4 Million
Q4 2022 Feb 14, 2023	BUY	$5.09 - $9.05 $4.24 Million - $7.54 Million	832,618 Added 22.31%	4,564,139 $25.6 Million
Q3 2022 Nov 15, 2022	BUY	$3.5 - $7.2 $7.94 Million - $16.3 Million	2,267,176 Added 154.83%	3,731,521 $24 Million
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.62 $9.14 Million - $25.8 Million	-3,383,598 Reduced 69.79%	1,464,345 $5.02 Million
Q1 2022 May 16, 2022	BUY	$6.3 - $8.84 $392,830 - $551,209	62,354 Added 1.3%	4,847,943 $34.5 Million
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $31.4 Million - $59.6 Million	-5,217,802 Reduced 52.16%	4,785,589 $39.9 Million
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $35.7 Million - $148 Million	6,539,118 Added 188.76%	10,003,391 $69.6 Million
Q2 2021 Aug 16, 2021	BUY	$18.46 - $24.36 $1.73 Million - $2.28 Million	93,453 Added 2.77%	3,464,273 $82.6 Million
Q1 2021 May 17, 2021	SELL	$17.66 - $28.92 $4.44 Million - $7.27 Million	-251,252 Reduced 6.94%	3,370,820 $69.4 Million
Q4 2020 Feb 16, 2021	BUY	$23.25 - $37.73 $62.8 Million - $102 Million	2,702,603 Added 293.93%	3,622,072 $88.7 Million
Q3 2020 Nov 10, 2020	BUY	$3.74 - $28.74 $383,537 - $2.95 Million	102,550 Added 12.55%	919,469 $26 Million
Q2 2020 Aug 14, 2020	BUY	$3.04 - $6.2 $462,089 - $942,418	152,003 Added 22.86%	816,919 $3.89 Million
Q1 2020 May 11, 2020	BUY	$2.64 - $3.82 $1.76 Million - $2.54 Million	664,916 New	664,916 $2.37 Million

Others Institutions Holding MCRB

# of Institutions

Shares Held

39.5M

Call Options Held

103K

Put Options Held

53K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $1.75B
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Seres Therapeutics, Inc. Transaction History